CD59 and ovarian carcinoma: When taken as overall, the levels of CD59, kininogen-1 and ITIH4 fragment were significantly lower in ovarian carcinoma patients by 3.6-, 2.5- and 1.9-folds, respectively, compared to those excreted by the control subjects.